These authors noted a 72% morbidity rate after surgery in intravenous drug-using AIDS patients; this rate was very similar to that found in homosexuals. However, the postoperative mortality rate was much lower in the heterosexual group than in the homosexual patients. This was attributed to the absence of cytomegalovirus ileocolitis and visceral malignancies in the intravenous drug abuser population. These AIDS manifestations have been found to cause the majority of morbidity in the homosexual AIDS group'', Another significant finding in the Wolkomir study was the failure of at least one-third of the anorectal wounds to heal more than 4 weeks after surgery. In 1986, we reviewed the results of 73 anorectal surgical procedures performed on 51 AIDS, AIDS-related complex, and AIDS prodrome patients". Forty-nine of the 51 patients in that study admitted to either homosexual or bisexual behaviour and the history was absent in the remaining two patients. It is imperative that one realizes neither the ELISA nor the Western blot test were available for confirmation of serum mvpositivity prior to or even after surgical intervention. These tests were not developed until after publication of that manuscript. Therefore, by definition, the 51 patients who underwent surgery had AIDS-related symptoms. Since the publication of that manuscript, neither the term AIDS-related complex nor AIDS-prodrome are in use. All of these patients would currently be classified as Centers for Disease Control Stages III or IV patients", In the 1986 study, 22 patients died within 6 months of surgery, six had healing in between 1 and 6 months, and 17 patients required more than 6 months to heal their wounds. There was a direct correlation between white blood cell count and adequacy of healing. This correlation was also shown by Wolkomir and colleagues'. More recently, Carr and co-workers retrospectively reviewed the outcome of anorectal surgery in 34 homosexual patients, 16 of whom were positive for the human immunodeficiency virus", Patients were followed for a minimum of6 weeks after surgery, and although the wounds healed within 6 weeks of surgery in all HIV-negative and asymptomatic HIVpositive patients, only one of the 9 wounds in the symptomatic HIV-positive population had healed at 6 weeks follow-up. Clearly, these results parallel those described in our initial 1986 study.
Safavi and colleagues noted a 68% incidence of healing in the asymptomatic HIV-positive group after 0141-0768/91/ 040191-021$02.00/0 © 1991 The Royal Society of Medicine anorectal surgery compared with only a 25% of healing in the symptomatic HIV-positive patients", Similar findings have been reported by Moenning and co-workers in which the postoperative morbidity in the AIDS population was 62% and the rate of recurrence of disease 56%7.
All of these studies point to the same conclusion: the asymptomatic HIV-positive individual can probably betreated more aggressively than can the symptomatic HIV-positive individual. The rationale for this is even more apparent if one realizes that the incidence of known HIV positivity in the urban clinic population is approximately 3%7. Wakeman and co-workers have suggested that major abdominal procedures can be performed in the asymptomatic HIV-positive population. This may be true, provided one is cognizant of the specific disease process. Clearly, it is the manifestation of HIV disease or AIDS, not the presence of the HIV itself which mitigates the aggressiveness which one can reasonably have when providing surgical intervention.
Another important point for consideration is that in previous years patients with HIV disease who underwent surgery were not undergoing immunostimulatory therapy. It has now been unequivocably shown that zidovudine can delay the progression of the stage HIV disease to full blown AIDSB. Considering all of these data together, the following recommendations can be made: (l) Patients with symptomatic HIV disease (AIDS; Centers for Disease Control Stages III or IV) should be treated conservatively and nonoperatively whenever possible; (2) patients with HIV-positive disease who have CD4 helper cell counts less than 500 per cubic millimetre should be started on zidovudine based on the findings of Volberding and co-workers''; (3) patients with early stage HIV disease with CD4 helper cell counts greater than 500 can probably be treated aggressively for benign anorectal disease including condylomata, fissures, and sepsis. I personally consider it advisable to distinguish fissures from ulcers in this population as sphincterotomy performed for an HIV, cytomegalovirus, or herpetic ulcer will almost certainly result in faecal incontinence. For this reason, I recommend biopsy for viral culture from all perianal ulcerations in the HIV-positive population prior to definitive therapy. Moreover, drainage of an abscess should be followed not only by routine aerobic and anaerobic cultures, but by specific anaerobic testing for Neisseria gonorrhoeae and Neisseria meningitidis as well as acid fast staining for Mycobacterium avium intracellulare. Armed with this knowledge, the coloproctologist can safely approach anorectal disease in the HIV-positive patient.
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